Skip to main content

Arax Advisory Partners

Position in LLY — ELI LILLY & Co

CIK 1586767 DENVER, CO

Position in LLY

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,436,550
-$2,900,270 QoQ
Shares Held
6,998
-19.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. LLY ranks #4 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 LLY
ELI LILLY & Co
This page
6,998 $6,436,550

All Filings in LLY

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,436,550 6,998
2025-12-31 $9,336,820 8,688
2025-09-30 $17,215,569 22,563
2025-06-30 $2,365,873 3,035
2025-03-31 $2,037,519 2,467
2024-12-31 $2,063,556 2,673
2024-09-30 $2,183,841 2,465
2024-06-30 $2,215,464 2,447
2024-03-31 $1,518,577 1,952
2023-12-31 $1,164,091 1,997
2023-09-30 $1,154,829 2,150
2023-06-30 $1,024,252 2,184
2023-03-31 $747,281 2,176
2022-12-31 $760,581 2,079
2022-09-30 $633,766 1,960
2022-06-30 $812,196 2,505
2022-03-31 $462,487 1,615
2021-12-31 $441,123 1,597
2021-09-30 $368,293 1,594
2021-06-30 $355,067 1,547
2020-12-31 $258,662 1,532
2020-09-30 $226,174 1,528
2020-06-30 $234,613 1,429
2020-03-31 $197,676 1,425